Servier Pharmaceuticals is pleased to announce the appointment of Jérôme Klein as Chief Strategy and Business Excellence Officer. 

Jérôme brings more than 20 years of experience in corporate strategy, commercial operations, and organizational transformation to this role. Most recently, he served as Global Head of Corporate Strategy and Secretary to Servier’s Executive Committee, where he led enterprise-level strategic initiatives and supported key business decisions across the Group. In his new position, Jérôme will lead strategy and Business Excellence functions, helping drive organizational effectiveness and support the company’s continued growth and innovation objectives. 

Jerome’s appointment reflects the continued evolution of Servier’s business and its commitment to building the leadership capabilities needed for the next phase of growth. His experience leading enterprise-wide initiatives and transformation efforts across the Group will help strengthen Servier’s strategic and business excellence capabilities as it continues to expand its portfolio and advance its mission to bring innovative medicines to patients.  

Throughout his career, Jérôme has demonstrated a strong ability to translate strategy into execution while fostering collaboration across complex organizations. Prior to joining Servier in 2023, he spent more than 15 years at Ipsen in a variety of international leadership roles spanning corporate strategy, financial planning, business intelligence, customer excellence, and commercial operations. He also played a key role in supporting external growth partnerships and later led Ipsen’s Neuroscience and Rare Diseases Business Unit in France.  

Jérôme holds a Master of Science in Management with a specialization in Finance from HEC Paris and completed studies at Copenhagen Business School.